Pregled bibliografske jedinice broj: 737417
Treatment with haloperidol and changes in glucose values in patients with schizophrenia
Treatment with haloperidol and changes in glucose values in patients with schizophrenia // European Archive of Psychiatry and Clinical Neuroscience 261 (Suppl 1) - Abstracts of the 3rd European Conference on Schizophrenia Research
Berlin, Njemačka: Springer, 2011. str. S65-S66 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 737417 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Treatment with haloperidol and changes in glucose values in patients with schizophrenia
Autori
Kozumplik, Oliver ; Uzun, Suzana ; Mimica, Ninoslav ; Jakovljević, Miro
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
European Archive of Psychiatry and Clinical Neuroscience 261 (Suppl 1) - Abstracts of the 3rd European Conference on Schizophrenia Research
/ - : Springer, 2011, S65-S66
Skup
3rd European Conference on Schizophrenia Research
Mjesto i datum
Berlin, Njemačka, 29.09.2011. - 01.10.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Glucose; Patient; Schizophrenia; Haloperidol
(glucose; patient; schizophrenia; haloperidol)
Sažetak
Results: Patient, 39 years old, with diagnosis of schizophrenia, was in psychiatric treatment for the past 20 years. The patient's compli-ance with previous oral antipsychotic therapy was poor and for that reason she was treated with haloperidol depot during period of 5 years. The patient occasionally had ideas of reference, but with such treatment she was able to function in her social activities and at work. At control examination, the patient reported often being thirsty and also reported frequent urination. The laboratory exami-nation and examination of specialist of internal medicine were advised. Results of laboratory examination showed glucose value above the reference range. In the same time, there was no change in patient's body weight. Also, there was no change in patient's diet. Treatment with haloperidol was discontinued and treatment with fluphenazine was initiated, again as depot injection, because of poor compliance with oral antipsychotic therapy. The patient responded well to such therapy, she was able to function in her social activities and at work, and values of glucose gradually returned to previous values (within reference range).Conclusion: Laboratory examination showed glucose value above the reference range in the patient who was treated with haloperidol depot ; after switching to fluphenazine depot values of glucose gradually returned to previous values (within reference range). Policy of full disclosure: None.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE